详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Comparison of two different regimens of intravenous methylprednisolone for patients with moderate to severe and active Graves’ ophthalmopathy: A prospective, randomized controlled trial

文献详情

资源类型：

Pubmed体系：

作者：

单位： [a]department of endocrinology and metabolism,the affiliated tongji hospital,tongji medical college,huazhong university of science & technology,wuhan,430030,china [b]department of radiology,the affiliated tongji hospital,tongji medical college,huazhong university of science & technology,wuhan,430030,china [c]department of ophthalmology,the affiliated tongji hospital,tongji medical college,huazhong university of science & technology,wuhan,430030,china

出处：

DOI：

ISSN：

关键词： Graves’ ophthalmopathy Magnetic resonance imaging Methylprednisolone

摘要：

The intravenous methylprednisolone (iv MP) strategy for Graves’ ophthalmopathy (GO) and evaluation of its activity against the disease warrants further exploration. A prospective randomized controlled trial for 3 months was performed in a tertiary referral teaching hospital to compare the efficacy and safety of two different regimens of iv MP, and determine the value of clinical activity score (CAS) and T2 relaxation time (T2RTs) and areas of extraocular muscles (EOMs) by magnetic resonance imaging for diagnosis of active GO. Forty patients with moderate to severe GO and CAS ≥ 3 or 1 ≤ CAS < 3 with prolonged T2RTs on EOMs were randomly assigned to a monthly (MR: 1.5 g iv MP monthly for 3 months) or weekly (WR: 0.5 g iv MP weekly for 6 weeks, followed by 0.25 g weekly for 6 weeks) regimen. Overall response based on ophthalmic symptoms, T2RTs, areas of EOMs and adverse effects were recorded at each visit. The total rate of response was 71.9%. Rates of improved, unchanged, deteriorated were similar between the MR and WR groups (p>0.05). The maximum T2RTs and areas significantly decreased at the end of intervention in both groups (p<0.05). Results show that both MR and WR are effective and safe in treatment of GO. T2RTs combined with CAS can sensitively detect active GO and predict the response to iv MP. © The Japan Endocrine Society.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2016]版：

大类 | 4 区医学

小类 | 4 区内分泌学与代谢

最新[2025]版：

大类 | 4 区医学

小类 | 4 区内分泌学与代谢

第一作者：

第一作者单位： [a]department of endocrinology and metabolism,the affiliated tongji hospital,tongji medical college,huazhong university of science & technology,wuhan,430030,china

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]眼眶磁共振成像T2-Mapping诊断活动性Graves眼病的临床应用 [2]双指数表观扩散系数鉴别诊断椎体良、恶性病变 [3]Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy [4]Estimation of Multiple Sclerosis lesion age on magnetic resonance imaging [5]Glioma-targeting micelles for optical/magnetic resonance dual-mode imaging [6][Functional magnetic resonance imaging in glaucoma]. [7]Prostate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint. [8]Magnetic resonance imaging features of gelatinous pseudocysts in cryptococcal meningoencephalitis [9]Serial magnetic resonance imaging representation in a Bald's concentric sclerosis [10]T2 Relaxation Time in Extraocular Muscles of Patients with Mild Thyroid- Associated Ophthalmopathy: Comparing T2 Mapping With and Without Fat Suppression Using Different Measurement Methods